Sentences with phrase «first of a new class of drugs»

TUESDAY, April 17, 2018 (HealthDay News)-- The millions of Americans who suffer from migraine may have a new source of hope — the first of a new class of drugs aimed at warding off the headaches.

Not exact matches

OCA is the first in a new class of drugs, farnesoid X receptor (FXR) agonists, and the response of the patients to OCA shows that abnormalities in the system it targets may be critical for this condition.

In August, for the first time in more than a decade, the FDA approved a new class of antiretroviral drugs called entry inhibitors.

He notes, however, that in the wake of the criminalization of first - generation cathinone derivatives, new members of this drug class are being invented that will also require study.

Sangamo biochemist Philip Gregory notes that this Phase 1 clinical trial is the first human test of an entirely new class of drug that could turn any gene on or off, depending on the disease.

«We first tried a histone methylation inhibitor — a promising new class of cancer drugs — but that did not restore p16 or had any effect on tumor growth.

«This study is the first step in a potential drug development for a new class of drugs for osteoarthritis, although there are a number of hurdles we have to go through — necessarily so — before it gets nearer patients.

A «game changing» new antibiotic which is capable of killing superbugs has been successfully synthesised and used to treat an infection for the first time — and could lead to the first new class of antibiotic drug in 30 years.

The first three - dimensional image capturing a critical malaria «conductor» protein could lead to the development of a new class of antimalarial drugs.

The good news is that since 2005, the WHO has been coordinating a worldwide effort to find new TB drugs, and as of December 2013 two new classes of drug had been approved, the first for 40 years.

Early results from a phase I, first in - human study indicate that a potential new class of drugs, RNA interference (RNAi) drugs, can be safely administered in humans, according to a researcher who presented data on the safety and preliminary efficacy of TKM - 080301 at the AACR Annual Meeting 2013, held in Washington, D.C., April 6 - 10.

Tu also received numerous awards nationally which include «Award for Progress in Anti-malarial Research Achieved by Project 523 Scientific Team» honored by China National Congress of Science and Technology (1978); «National Scientific Discovery Award» for Anti-malaria Drug - Qinghaosu by the China Ministry of Science and Technology (1979); «Invention Award» (as the first inventor) by China National Congress for Awards in Science and Technology (1982); «Award of Young and Middle - aged Experts with Outstanding Contribution» by the Chinese Government (1984); «The Top Honorary Award» by China Academy of Traditional Chinese Medicine (1992); «The Top Ten National Achievements for Progress in Science and Technology» by China National Committee of Science and Technology (1992); «First - Class Award of National Achievements in Science and Technology» by China National Award Committee for Advances in Science and Technology (1992); «National Model» by China State Council (1995); «Award for Outstanding Achievement in Traditional Chinese Medicine» by Guangzhou Zhongjing Award Foundation for Traditional Chinese Medicine (1995); «Outstanding Scientific Achievement Award» by Qiu Shi Science and Technologies Foundation of Hong Kong (1996); «Top Ten Health Achievements in New China» by China Ministry of Health (1997); «Female Inventor of the New Century» by China National Bureau of Intellectual Property (2002); «Golden Medal of the 14th National Invention Exhibition» by China National Bureau of Intellectual Property (2003); «Award for Development of Chinese Materia Medica» by Cyrus Chung Ying Tang Foundation, (2first inventor) by China National Congress for Awards in Science and Technology (1982); «Award of Young and Middle - aged Experts with Outstanding Contribution» by the Chinese Government (1984); «The Top Honorary Award» by China Academy of Traditional Chinese Medicine (1992); «The Top Ten National Achievements for Progress in Science and Technology» by China National Committee of Science and Technology (1992); «First - Class Award of National Achievements in Science and Technology» by China National Award Committee for Advances in Science and Technology (1992); «National Model» by China State Council (1995); «Award for Outstanding Achievement in Traditional Chinese Medicine» by Guangzhou Zhongjing Award Foundation for Traditional Chinese Medicine (1995); «Outstanding Scientific Achievement Award» by Qiu Shi Science and Technologies Foundation of Hong Kong (1996); «Top Ten Health Achievements in New China» by China Ministry of Health (1997); «Female Inventor of the New Century» by China National Bureau of Intellectual Property (2002); «Golden Medal of the 14th National Invention Exhibition» by China National Bureau of Intellectual Property (2003); «Award for Development of Chinese Materia Medica» by Cyrus Chung Ying Tang Foundation, (2First - Class Award of National Achievements in Science and Technology» by China National Award Committee for Advances in Science and Technology (1992); «National Model» by China State Council (1995); «Award for Outstanding Achievement in Traditional Chinese Medicine» by Guangzhou Zhongjing Award Foundation for Traditional Chinese Medicine (1995); «Outstanding Scientific Achievement Award» by Qiu Shi Science and Technologies Foundation of Hong Kong (1996); «Top Ten Health Achievements in New China» by China Ministry of Health (1997); «Female Inventor of the New Century» by China National Bureau of Intellectual Property (2002); «Golden Medal of the 14th National Invention Exhibition» by China National Bureau of Intellectual Property (2003); «Award for Development of Chinese Materia Medica» by Cyrus Chung Ying Tang Foundation, (2009).

Leelamine could be the first of a new unique class of drugs that will simultaneously target several protein pathways.

Leelamine is the first of a new class of potentially viable drugs for the treatment of melanoma.

Dr. Vilcek's contributions to the understanding of proteins that control the body's defenses were instrumental in the development of the anti-inflammatory drug Remicade ®, the first member of a new class of therapeutics called TNF blockers that are now widely used for the treatment of Crohn's disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriasis, and other chronic inflammatory disorders.

This candidate new drug, a first - in - its - class, shows activity against a broad range of tumor types in mice and appears safe at this stage.»

Reykjavik, ICELAND, January 13, 2005 — deCODE genetics (Nasdaq: DCGN) has submitted an investigational new drug application (IND) to the U.S. Food and Drug Administration (FDA) for DG041, a novel, first - in - class, orally - administered small molecule for the treatment odrug application (IND) to the U.S. Food and Drug Administration (FDA) for DG041, a novel, first - in - class, orally - administered small molecule for the treatment oDrug Administration (FDA) for DG041, a novel, first - in - class, orally - administered small molecule for the treatment of...

Invokana (canagliflozin) was the first drug of a new class of diabetes drugs known as sodium - glucose cotransporter - 2 (SGLT2) inhibitors.

More than one - third of the novel new drugs approved in 2014 (17 of 41 or about 41 %) were identified as First - in - Class and about 41 % of the novel new drugs approved in 2014 (17 of 41) were approved to treat rare or «orphan» diseases.